Mabion S.A. (WSE:MAB)
Poland · Delayed Price · Currency is PLN 7.37
+0.04 (0.55%)
Jul 24, 2026, 5:00 PM CET
Mabion Company Description
Mabion S.A., a biopharmaceutical company, provides contract development, analytics, and manufacturing services for biologics in Poland.
It offers drug substance manufacturing, process development, analytics, and cell line development services.
The company also provides medicines for cancer, autoimmune diseases, rare diseases, and other diseases.
The company was founded in 2007 and is headquartered in Konstantynów Lódzki, Poland.
Mabion S.A.
| Country | Poland |
| Founded | 2007 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 204 |
| CEO | Krzysztof Kaczmarczyk |
Contact Details
Address: Medical Biotechnology Scientific and Industrial Complex Konstantynów Lódzki, 95-050 Poland | |
| Phone | 48 42 207 7890 |
| Website | mabion.eu |
Stock Details
| Ticker Symbol | MAB |
| Exchange | Warsaw Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PLN |
| ISIN Number | PLMBION00016 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Krzysztof Robert Kaczmarczyk | Chief Executive Officer and President of Management Board |
| Julita Balcerek M.D. | Member of the Management Board, Operations Director and Chief Operating Officer |
| Adam Pietruszkiewicz | Chief Commercial Officer, Business Development Director and Member of Management Board |
| Pawel Pobiedzinski | Head of Logistics and Procurement |
| Joanna Krolasik | Head of Microbiology Division |
| Paulina Tobola | Head of Analytics Development Department |